Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal ganglion cell | 4 studies | 53% ± 25% |
Insufficient scRNA-seq data for expression of POU4F1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 75% | 16.29 | 1972 / 2642 | 28% | 1.01 | 195 / 705 |
skin | 66% | 10.70 | 1189 / 1809 | 23% | 0.84 | 110 / 472 |
muscle | 85% | 19.18 | 680 / 803 | 0% | 0 | 0 / 0 |
spleen | 76% | 8.19 | 184 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 54% | 18.69 | 726 / 1335 | 0% | 0 | 0 / 0 |
lung | 32% | 2.24 | 187 / 578 | 20% | 0.69 | 231 / 1155 |
intestine | 36% | 4.19 | 352 / 966 | 9% | 0.17 | 48 / 527 |
esophagus | 35% | 3.29 | 499 / 1445 | 11% | 0.51 | 20 / 183 |
peripheral blood | 39% | 10.30 | 364 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 1.38 | 16 / 45 |
breast | 27% | 1.83 | 123 / 459 | 7% | 0.29 | 83 / 1118 |
uterus | 9% | 0.53 | 15 / 170 | 24% | 0.90 | 110 / 459 |
lymph node | 0% | 0 | 0 / 0 | 31% | 1.03 | 9 / 29 |
pancreas | 27% | 1.74 | 88 / 328 | 3% | 0.13 | 6 / 178 |
stomach | 19% | 1.43 | 69 / 359 | 8% | 0.49 | 22 / 286 |
adipose | 25% | 2.04 | 299 / 1204 | 0% | 0 | 0 / 0 |
liver | 21% | 6.58 | 48 / 226 | 1% | 0.03 | 5 / 406 |
thymus | 20% | 1.89 | 128 / 653 | 1% | 0.02 | 7 / 605 |
prostate | 15% | 1.21 | 36 / 245 | 3% | 0.10 | 13 / 502 |
bladder | 5% | 1.24 | 1 / 21 | 13% | 0.52 | 63 / 504 |
ovary | 14% | 1.12 | 26 / 180 | 2% | 0.05 | 10 / 430 |
kidney | 11% | 0.83 | 10 / 89 | 4% | 0.25 | 33 / 901 |
adrenal gland | 9% | 0.44 | 22 / 258 | 5% | 0.18 | 12 / 230 |
heart | 7% | 0.45 | 64 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000679 | Biological process | positive regulation of transcription regulatory region DNA binding |
GO_0007498 | Biological process | mesoderm development |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007507 | Biological process | heart development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0031175 | Biological process | neuron projection development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0021953 | Biological process | central nervous system neuron differentiation |
GO_0048665 | Biological process | neuron fate specification |
GO_0001764 | Biological process | neuron migration |
GO_0003223 | Biological process | ventricular compact myocardium morphogenesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043069 | Biological process | negative regulation of programmed cell death |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0007409 | Biological process | axonogenesis |
GO_0021559 | Biological process | trigeminal nerve development |
GO_0045672 | Biological process | positive regulation of osteoclast differentiation |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0048935 | Biological process | peripheral nervous system neuron development |
GO_0072332 | Biological process | intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0021535 | Biological process | cell migration in hindbrain |
GO_0051355 | Biological process | proprioception involved in equilibrioception |
GO_0021986 | Biological process | habenula development |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0007416 | Biological process | synapse assembly |
GO_0051090 | Biological process | regulation of DNA-binding transcription factor activity |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0048880 | Biological process | sensory system development |
GO_0060384 | Biological process | innervation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0001967 | Biological process | suckling behavior |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043005 | Cellular component | neuron projection |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0051020 | Molecular function | GTPase binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | POU4F1 |
Protein name | POU domain, class 4, transcription factor 1 (Brain-specific homeobox/POU domain protein 3A) (Brain-3A) (Brn-3A) (Homeobox/POU domain protein RDC-1) (Oct-T1) |
Synonyms | BRN3A RDC1 |
Description | FUNCTION: Multifunctional transcription factor with different regions mediating its different effects. Acts by binding (via its C-terminal domain) to sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in the regulatory regions of its target genes. Regulates the expression of specific genes involved in differentiation and survival within a subset of neuronal lineages. It has been shown that activation of some of these genes requires its N-terminal domain, maybe through a neuronal-specific cofactor. Ativates BCL2 expression and protects neuronal cells from apoptosis (via the N-terminal domain). Induces neuronal process outgrowth and the coordinate expression of genes encoding synaptic proteins. Exerts its major developmental effects in somatosensory neurons and in brainstem nuclei involved in motor control. Stimulates the binding affinity of the nuclear estrogene receptor ESR1 to DNA estrogen response element (ERE), and hence modulates ESR1-induced transcriptional activity. May positively regulate POU4F2 and POU4F3. Regulates dorsal root ganglion sensory neuron specification and axonal projection into the spinal cord. Plays a role in TNFSF11-mediated terminal osteoclast differentiation. Negatively regulates its own expression interacting directly with a highly conserved autoregulatory domain surrounding the transcription initiation site. .; FUNCTION: [Isoform 2]: Able to act as transcription factor, cannot regulate the expression of the same subset of genes than isoform 1. Does not have antiapoptotic effect on neuronal cells. . |
Accessions | Q01851 ENST00000377208.7 [Q01851-1] |